{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:02:52Z","timestamp":1775505772143,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vancomycin-resistant enterococci (VR\u0415) are recognized as important hospital pathogens which have become common in patients admitted to the intensive care units (ICUs). The purpose of this study was to evaluate the incidence of and the risk factors for colonization with VRE among ICU patients. A total of 91 patients who had duration of hospitalization more than 48\u00a0h and without infection caused by VRE or\/and other microorganisms in the ICU at University Hospital, Pleven were screened for colonization with VRE. The following data were collected: demographic characteristics, clinical information and antimicrobials use. The statistical analysis was performed using SPSS version 27.0. Colonization with VRE was established in 22 patients and one was carrying two enterococcal species. A total of 23 VRE were isolated. The univariate analysis showed that the postoperative critical cares (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), cardiovascular diseases (<jats:italic>p<\/jats:italic>\u2009=\u20090.009) and the presence of an endotracheal tube (<jats:italic>p<\/jats:italic>\u2009=\u20090.003) were risk factors for colonization with VRE. Also, the postoperative critical cares (<jats:italic>p<\/jats:italic>\u2009=\u20090.021) and cardiovascular diseases (<jats:italic>p<\/jats:italic>\u2009=\u20090.018) were confirmed as independent risk factor for VRE acquisition by multivariate analysis. The prevalence of VRE colonization among the ICU patients was relatively high (24.2%). Risk factors for acquisition of intestinal VRE were the postoperative cares, cardiovascular diseases and the presence of an endotracheal tube.<\/jats:p>","DOI":"10.1186\/s13099-023-00564-x","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T08:02:23Z","timestamp":1690358543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Risk factors for gut colonization with vancomycin-resistant enterococci among Bulgarian critically ill patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Preslava M.","family":"Hristova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora V.","family":"Marinova-Bulgaranova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanya V.","family":"Strateva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan V.","family":"Trifonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hristina Y.","family":"Hitkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"564_CR1","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/j.ijid.2012.09.019","volume":"17","author":"KM Sohn","year":"2013","unstructured":"Sohn KM, Peck KR, Joo EJ, Ha YE, Kang CI, Chung DR, et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis. 2013;17:e240\u2013246.","journal-title":"Int J Infect Dis"},{"key":"564_CR2","doi-asserted-by":"publisher","first-page":"iii13","DOI":"10.1093\/jac\/dkg272","volume":"51","author":"R Patel","year":"2003","unstructured":"Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother. 2003;51:iii13\u201321.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"564_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jiac.2018.01.001","volume":"24","author":"J Monticelli","year":"2018","unstructured":"Monticelli J, Knezevich A, Luzzati R, Di Bella S. Clinical management of non-faecium non-faecalis vancomycin-resistant enterococci infection. Focus on Enterococcus gallinarum and Enterococcus casseliflavus\/flavescens. J Infect Chemother. 2018;24(4):237\u201346.","journal-title":"J Infect Chemother"},{"key":"564_CR4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bjid.2014.09.010","volume":"19","author":"A Kara","year":"2015","unstructured":"Kara A, Devrim I, Bayram N, Katipoglu N, K\u0131ran E, Oruc Y, et al. Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci. Braz J Infect Dis. 2015;19:58\u201361.","journal-title":"Braz J Infect Dis"},{"key":"564_CR5","doi-asserted-by":"publisher","first-page":"e128003","DOI":"10.5812\/jjm-128003","volume":"15","author":"P Hristova","year":"2022","unstructured":"Hristova P, Nankov V, Stoikov I, Ivanov I, Ouzounova-Raykova V, Hitkova H. Prevalence of genes encoding resistance to aminoglycosides and virulence factors among intestinal vancomycin-resistant enterococci. Jundishapur J Microbiol. 2022;15:e128003.","journal-title":"Jundishapur J Microbiol"},{"key":"564_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1590\/S1413-86702006000400004","volume":"10","author":"AT Tresoldi","year":"2006","unstructured":"Tresoldi AT, Cardoso LGO, Castilho GV, Dantas SRPE, von Nowakonski A, Pereira RM, et al. Low prevalence of vancomycin resistant enterococci colonization in intensive care patients in a brazilian teaching hospital. Braz J Infect Dis. 2006;10:239\u201341.","journal-title":"Braz J Infect Dis"},{"key":"564_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1590\/S0074-02762012000100008","volume":"107","author":"DWda Batistao","year":"2012","unstructured":"Batistao DWda, F, Gontijo-Filho PP, Concei\u00e7\u00e3o N, de Oliveira AG, Ribas RM. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz. 2012;107:57\u201363.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"564_CR8","doi-asserted-by":"publisher","first-page":"e75658","DOI":"10.1371\/journal.pone.0075658","volume":"8","author":"PD Ziakas","year":"2013","unstructured":"Ziakas PD, Thapa R, Rice LB, Mylonakis E. Trends and significance of VRE colonization in the ICU: a meta-analysis of published studies. PLoS ONE. 2013;8:e75658.","journal-title":"PLoS ONE"},{"key":"564_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1590\/S1413-86702005000100011","volume":"9","author":"GHC Furtado","year":"2005","unstructured":"Furtado GHC, Martins ST, Coutinho AP, Wey SB, Medeiros EAS. Prevalence and factors associated with rectal vancomycin-resistant enterococci colonization in two intensive care units in Sao Paulo, Brazil. Braz J Infect Dis. 2005;9:64\u20139.","journal-title":"Braz J Infect Dis"},{"key":"564_CR10","first-page":"DC06","volume":"10","author":"R Amberpet","year":"2016","unstructured":"Amberpet R, Sujatha Sistla SC, Parija. Molly Mary Thabah. Screening for intestinal colonization with vancomycin resistant enterococci and associated risk factors among patients admitted to an adult intensive care unit of a large teaching hospital. J Clin Diagnostic Res. 2016;10:DC06\u20139.","journal-title":"J Clin Diagnostic Res"},{"key":"564_CR11","doi-asserted-by":"publisher","first-page":"e7694","DOI":"10.5867\/medwave.2019.08.7694","volume":"19","author":"L Duarte","year":"2019","unstructured":"Duarte L, Arbo A, Gallardo M, Riquelme I, Delgadillo L, Jimenez HJ. Factors associated with vancomycin-resistant enterococci colonization in a pediatric intensive care unit of Paraguay: a cross-sectional study on hospital charts. Medwave. 2019;19:e7694\u20134.","journal-title":"Medwave"},{"key":"564_CR12","doi-asserted-by":"publisher","first-page":"e47297","DOI":"10.1371\/journal.pone.0047297","volume":"7","author":"SC Pan","year":"2012","unstructured":"Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, Chang SC. Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS ONE. 2012;7:e47297.","journal-title":"PLoS ONE"},{"key":"564_CR13","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1093\/jac\/dkr204","volume":"66","author":"YK Yoon","year":"2011","unstructured":"Yoon YK, Lee SE, Lee J, Kim HJ, Kim JY, Park DW, et al. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study. J Antimicrob Chemother. 2011;66:1831\u201338.","journal-title":"J Antimicrob Chemother"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-023-00564-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13099-023-00564-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-023-00564-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T08:03:08Z","timestamp":1690358588000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-023-00564-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1186\/s13099-023-00564-x","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics board of Medical University \u2013 Pleven. Data processing was anonymized and complied with local data protection legislation (No 512\/2018) and with the European Directive on the Privacy of Data (95\/46\/EC).All subjects that participated of this study gave a written informed consent in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}